Target intelligence / Profile preview

Nucleotide exchange factor SIL1 (SIL1)

Target
SIL1
Molecular classification
Co-chaperone protein, Nucleotide exchange factor (NEF), Endoplasmic reticulum-resident protein
01

Overview

Nucleotide exchange factor SIL1 (SIL1) is a protein encoded by the SIL1 gene, localized in the endoplasmic reticulum of eukaryotic cells. Its primary function is as a co-chaperone for the ER-resident Hsp70 chaperone BiP (also known as GRP78). SIL1 catalyzes the exchange of ADP for ATP on BiP, thereby facilitating BiP’s ATP-dependent protein folding cycle and ensuring proper folding and quality control of newly synthesized proteins as well as refolding of misfolded proteins. Additional roles include facilitating the release of protein substrates from BiP and modulating BiP’s activity in response to cellular redox changes. Mutations in SIL1 disrupt these critical processes and cause Marinesco-Sjögren syndrome, characterized by multisystem involvement particularly affecting neuromuscular function and protein homeostasis. SIL1 is not currently recognized as a direct clinical drug target, nor are there approved drugs or associated biomarkers for its direct modulation.

Other names
BiP-associated protein (BAP)MSSSIL1 homolog, endoplasmic reticulum chaperoneSIL1 proteinSIL1_HUMANULG5UNQ545/PRO836
02

Mechanism of action

null (not a known therapeutic target; mechanism of action not defined for drugs)

03

Biological functions

Protein folding assistance in endoplasmic reticulumRegulation of BiP chaperone cycle through ADP release and ATP bindingPrevention of extended BiP-substrate interaction (peptide release)Reductase activity on BiP (redox regulation under oxidative stress)Modulation of unfolded protein response and proteostasis
04

Disease associations

Marinesco-Sjögren syndrome (caused by SIL1 deficiency/mutation)Other diseases arising from disrupted proteostasis (suggested: cancer, diabetes, neurodegeneration, via general proteostasis dysregulation)

Beyond the preview

Go deeper on Nucleotide exchange factor SIL1 (SIL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleotide exchange factor SIL1 (SIL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call